Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents - Wikidata - wikimedia - TriplyDB

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

http://www.wikidata.org/entity/Q33691239

about

Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae Antipneumococcal activity of ABT-773 compared to those of 10 other agents.Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia Antistreptococcal activity of AR-709 compared to that of other agents.Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumon Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA.Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers.Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.

P2860

Q30662421-870577FE-C275-4DB0-88ED-E4BD2F35B75C Q33555366-3E61A5DB-4E1E-4CD5-B178-E1B40E2150FA Q33702256-228BA50B-E002-40BD-9BB3-285D39AFB829 Q33966371-FCE883A8-EEC8-4F3F-818D-79CE7391C49B Q33977456-D60150C9-7C5C-4CB3-8722-636CB85CA2A3 Q33978781-34517EC7-FD90-4C50-A9B5-5F3DB0C109C1 Q33980037-ACCB3EA3-1054-4750-ABED-8E05326B289E Q33981093-BAD48949-2499-4623-946F-3CB65E5DAD5E Q33981117-8A9AE364-0010-4657-A6FD-E076C578346E Q33982849-3DF1A642-05D0-4C36-A659-E8312C7E53E5 Q34105515-E900D29A-E066-4CF8-9848-68BC174AED90 Q34105521-10990D95-164E-4824-9D87-19296FA118C2 Q34107785-069D0852-CEDD-44EF-B0D7-64C5DD1D09EC Q34112023-06B92296-3D65-4FC4-9BD5-9F6D6623DA66 Q34112665-3D58C794-033C-4E3B-B89B-72010C5A820F Q35102381-843F3876-9D1F-488C-87F3-740737AAF3DC Q35547345-0A94EC10-687F-4547-82CB-3E0D6ED1DDA5 Q37116814-725AD82A-215A-4C5E-9ED6-A5327EB16F15 Q38898215-FE12DEEC-C5C7-4AC5-A2E2-742C412BEE61 Q39478959-D3BF6AED-72D0-4836-BC71-0E65409B627F Q39651945-2A5BE2D7-7426-44BE-8F9F-32BE6B8E6C95 Q39652910-DECE341B-1990-4A13-A2C3-E1A82DC92300 Q40165104-2FC6BFBD-D986-4171-8AE7-0E02AEBF5D23 Q40290408-32996ACF-C16A-4882-A239-F2E4461A1732 Q40733036-9EBC6E60-F216-4425-B5CE-43B26BE79199 Q42112713-A0F64ECF-49AC-4587-B95B-0F3160FA404F Q48139081-5A117785-FD2E-4DCA-B126-BA9AF91B9FF2

P2860

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

http://www.wikidata.org/entity/Q33691239

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@ast

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@en

type

label

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@ast

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@en

prefLabel

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@ast

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@en

P1433

Q33691239-6547463A-95C4-4301-BFD0-25810C3DAF76

P1476

Q33691239-20954E53-64F9-4FBA-8889-F7EC24FA0C30

P2093

Q33691239-4D0A33AE-A7E3-4C78-9818-F22B0E2DF23A

Q33691239-5F234EEA-5194-4763-8655-46BC28B6E5B0

Q33691239-639A45A8-0B55-4C44-B691-A75C0A8E6A1E

Q33691239-CD2E6F6D-5F7E-41DE-BDD7-F197BC432819

P2860

Q33691239-13CAB342-40A0-4799-B548-C75F6750EDEF

Q33691239-1E3AD71D-3D40-4813-9C99-3897CBAD48BC

Q33691239-2DBC6C9E-3E05-4964-9369-C63D2794E8B5

Q33691239-2FF6C90E-2A9A-44EF-91A6-72F382C65F34

Q33691239-3830FD0F-7147-4507-8854-C6A85DAFF122

Q33691239-5806AAD9-A706-4ACD-8220-CE1929FF341D

Q33691239-6543A874-64B8-4346-9CF4-8E441C3462AB

Q33691239-6EEFE73C-184E-46AF-A5FB-D113345CAE15

Q33691239-709020C5-ED2E-4C2B-ADBB-3BF3FAB10EC6

Q33691239-732E92B3-B298-44AC-96C1-60697AA19C3C

P304

Q33691239-9A675D07-6E63-4053-B724-333B5D58670A

P31

Q33691239-3F68446E-68B9-4BAE-A373-3499C9DE780C

P356

Q33691239-9A49725F-6012-44B0-889E-27AF2CDE4B9B

P407

Q33691239-813C9BBB-F2A6-4E23-A9EB-69210C40CBE9

P433

Q33691239-89CF54CA-556D-44E8-A869-8D14E83D6C45

P478

Q33691239-55DB8DBC-E58D-4B63-859D-42B92AD68A46

P577

Q33691239-B6D0C4B6-059D-4599-B9DE-4DA991059C76

P698

Q33691239-8EA1997B-A690-4180-A449-8714F32F1793

P932

Q33691239-5FEAE40A-D313-478F-931E-0FAB0A7C2584

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Susceptibilities of penicillin ...... ptibilities to 17 other agents

@en

P2093

G A Pankuch

http://www.w3.org/2001/XMLSchema#string

M A Visalli

http://www.w3.org/2001/XMLSchema#string

M R Jacobs

http://www.w3.org/2001/XMLSchema#string

P C Appelbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods.

In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004

Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.

In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.

In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, a

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.

P304

624-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.3.624

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9517943

http://www.w3.org/2001/XMLSchema#string

P932

105509

http://www.w3.org/2001/XMLSchema#string